Blog cover about impurity fate mapping for pharmaceutical intermediates, purge assessment and COA limitations, ICH M7 Option 4 pharmaceutical quality analysis graphic, professional dark‑blue‑grey tech background
blog, Buyer Resources

Impurity Fate Mapping: 5 Documents Buyers Should Request

An impurity absent from a Certificate of Analysis is not necessarily absent from the process — it may simply have been purged downstream. This guide explains impurity fate mapping, purge factors, ICH M7 Option 4, and the five documents buyers should request.